The forecast for neoplasm mortality among females in the US shows a steady increase from 294.8 thousand in 2024 to 297.36 thousand by 2028. Compared to the predicted 2023 level, which similar data suggests stood slightly above this range, the annual growth rate from 2024 is marginally low, at approximately 0.56% on average over these years. This indicates a stable but concerning rise in mortality due to neoplasms.

Future trends to watch for include:

The impact of medical advancements on early detection and treatment efficiencies.
Demographic shifts and lifestyle changes that may influence cancer incidence rates.
Policy changes aimed at improving healthcare access and cancer management.